Categories Earnings, Health Care

AngioDynamics (ANGO): Q2 2020 Earnings Snapshot

— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected.

— Net sales remained flat at $70 million, vs. $71.2 million expected.

— US net sales grew 1.8% to $55.6 million.

— International net sales increased 5.6% to $14.4 million.

— Oncology net sales rose 5.1% to $16.1 million.

— Vascular Interventions and Therapies net sales grew 0.6% to $31.2 million.

— Vascular Access net sales fell 4% to $22.8 million.

— FY2020 net sales are expected to be $280-286 million.  

— FY2020 adjusted EPS is expected to be $0.10-0.15.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

AVGO Earnings: All you need to know about Broadcom Q1 2021 earnings results

Broadcom Limited (NASDAQ: AVGO) reported first quarter 2021 earnings results today. Total revenue increased 14% year-over-year to $6.65 billion. GAAP net income was $1.3 billion, or $3.05 per share, compared

Infographic: Costco (COST) Q2 2021 sales up 15%; earnings miss

Retail giant Costco Wholesale Corporation (NASDAQ: COST) reported higher earnings and revenues for the second quarter of 2021. Earnings missed analysts’ expectations, while sales beat. Net profit was $951 million

Will shifting to as-a-service model help Hewlett Packard in emerging stronger from COVID?

With the corporate world rapidly shifting to cloud-native computing after the virus outbreak changed work culture and the way businesses operate, technology providers are aggressively innovating their offerings. Hewlett Packard

Add Comment
Viewing Highlight